Celltrion And Teva Catch Up On Canadian Trastuzumab

 
• By Dave Wallace

Celltrion and Teva have now received a Health Canada approval for their Herzuma trastuzumab biosimilar. However, notices of compliance have already been granted for rival biosimilars from Mylan and Pfizer.

Canada_Thumbs_Up
Health Canada has approved Celltrion and Teva’s trastuzumab biosimilar • Source: Shutterstock

More from Biosimilars

More from Products